First CYP450 structure published
Astex Technology has published the first three-dimensional study of
a human cytochrome P450 protein involved in drug metabolism in the
Caliper completes Zymark purchase
Caliper Technologies has completed its $71 million (€61m)
acquisition of Zymark, a privately held provider of laboratory
automation, liquid handling and robotics systems.
Biomarker study shows drug causes apoptosis
An inhibitor of cyclin dependent kinase (CDK) originated by UK
biopharmaceutical company Cyclacel has generated encouraging data
in a Phase I trial.
Biofrontera buys natural compound firm
Biofrontera Pharmaceuticals has taken over the entire operations of
bioLeads, a company specialising in sourcing natural compounds from
EC unveils €411m fund for genomics research
The European Commission has published a call for research proposals
in the area of life sciences, genomics and biotechnology for
Tissue microarray use on the rise
There is a growing reliance on the use of tissue microarrays to
accelerate the examination of histological samples used in drug
discovery, according to a new report from BioInformatics.
Ambion launches first SARS control
RNA specialist Ambion has introduced what it claims is the first
commercially available positive control for use in the detection of
the SARS virus.
Plant compounds for cancer control
MolecularNature has forged a drug discovery partnership with Zetiq
Technologies that has already yielded a number of novel cancer
ALA LabFusion springs from ISLAR ashes
This year's ISLAR meeting - the last ever to be held - will be
replaced in 2004 by a new Association of Laboratory Automation
conference called LabFusion.
Karo Bio cuts losses as R&D progresses
Swedish drug discovery company Karo Bio has trimmed its losses down
to SEK18.1 million in the second quarter of 2003 from SEK79.7
million a year earlier.
EU states taken to ECoJ over biotech
European Commission refers eight EU member states to the European
Court of Justice over their alleged failure to implement legal
protection of biotech inventions.
Amersham extends CyDye fluor range
Amersham Biosciences has added to its range of CyDye mono-reactive
fluor dyes with two products used for labelling proteins or
antibodies in protein array experiments.
4SC and Esteve extend CNS project
A pilot project aimed at identifying new drug candidates for
central nervous system disorders, initiated by Germany's 4SC and
Spain's Esteve, has grown into a full-blown collaboration between
Swedish BioTech Forum planned for November
The Karolinska Institute, together with the Swedish academy of
pharmaceutical sciences, is organising BioTech Forum 2003, to take
place from 26 to 28 November in Stockholm, Sweden.
Expressionist paints picture of cancer genetics
Genedata's Expressionist software is to be used in a cancer
research effort in Singapore aimed at developing clinical
diagnostics and identifying novel drug targets.